Skip to main content
. 2022 Jan 25;12:1317. doi: 10.1038/s41598-022-05243-6

Figure 5.

Figure 5

PDSs in breast cancer. (A) Differences in survival comparing different treatment strategies in the METABRIC/Curtis dataset. LR-p p-value calculated between TP53 groups using Log-rank test, DSS disease-specific survival. (B) PDSs compared between distinct treatment groups. (C) PDSs for breast cancer subtypes in METABRIC/Curtis dataset. (D) KM plots evaluating the association between PDS and survival in the METABRIC/Curtis dataset within PAM50 breast cancer subtypes. LR-p p-value calculated between TP53 groups using Log-rank test, Cox-p p-value calculated using Coxph regression using PDSs as continuous variable, DSS disease-specific survival.